Pfizer, BioNTech say updated vaccines offer ‘substantially higher immune response’ against omicron

Pharmaceutical and biotechnology companies Pfizer and BioNTech announced Saturday that updated versions of their vaccines that were adapted to the omicron variant of COVID-19 deliver a “substantially higher immune response” against the strain.

Studies “found that a booster dose of…

Source: thehill.comRead more